Toyoda H - Search Results

1

Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.

Taylor RS, Taylor RJ, Bayliss S, Hagström H, Nasr P, Schattenberg JM, Ishigami M, Toyoda H, Wai-Sun Wong V, Peleg N, Shlomai A, Sebastiani G, Seko Y, Bhala N, Younossi ZM, Anstee QM, McPherson S, Newsome PN. Taylor RS, et al. Among authors: toyoda h. Gastroenterology. 2020 May;158(6):1611-1625.e12. doi: 10.1053/j.gastro.2020.01.043. Epub 2020 Feb 4. Gastroenterology. 2020. PMID: 32027911 Free article.

2

Efficacy of ribavirin plus interferon-alpha in patients aged >or=60 years with chronic hepatitis C.

Honda T, Katano Y, Urano F, Murayama M, Hayashi K, Ishigami M, Nakano I, Yoshioka K, Toyoda H, Kumada T, Goto H. Honda T, et al. Among authors: toyoda h. J Gastroenterol Hepatol. 2007 Jul;22(7):989-95. doi: 10.1111/j.1440-1746.2006.04773.x. J Gastroenterol Hepatol. 2007. PMID: 17608843

3

Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma.

Kuzuya T, Katano Y, Kumada T, Toyoda H, Nakano I, Hirooka Y, Itoh A, Ishigami M, Hayashi K, Honda T, Goto H. Kuzuya T, et al. Among authors: toyoda h. J Gastroenterol Hepatol. 2007 Nov;22(11):1929-35. doi: 10.1111/j.1440-1746.2006.04707.x. J Gastroenterol Hepatol. 2007. PMID: 17914972

4

Association of hepatitis B virus subgenotypes and basal core promoter/precore region variants with the clinical features of patients with acute hepatitis.

Hayashi K, Katano Y, Takeda Y, Honda T, Ishigami M, Itoh A, Hirooka Y, Nakano I, Yoshioka K, Toyoda H, Kumada T, Goto H. Hayashi K, et al. Among authors: toyoda h. J Gastroenterol. 2008;43(7):558-64. doi: 10.1007/s00535-008-2197-2. Epub 2008 Jul 23. J Gastroenterol. 2008. PMID: 18648743

5

Mutations in the interferon sensitivity-determining region of hepatitis C virus genotype 2a correlate with response to pegylated-interferon-alpha 2a monotherapy.

Hayashi K, Katano Y, Honda T, Ishigami M, Itoh A, Hirooka Y, Nakano I, Urano F, Yoshioka K, Toyoda H, Kumada T, Goto H. Hayashi K, et al. Among authors: toyoda h. J Med Virol. 2009 Mar;81(3):459-66. doi: 10.1002/jmv.21407. J Med Virol. 2009. PMID: 19152412

6

Efficacy of peginterferon-alpha-2b plus ribavirin in patients aged 65 years and older with chronic hepatitis C.

Honda T, Katano Y, Shimizu J, Ishizu Y, Doizaki M, Hayashi K, Ishigami M, Itoh A, Hirooka Y, Nakano I, Urano F, Yoshioka K, Toyoda H, Kumada T, Goto H. Honda T, et al. Among authors: toyoda h. Liver Int. 2010 Apr;30(4):527-37. doi: 10.1111/j.1478-3231.2009.02064.x. Epub 2009 Jun 12. Liver Int. 2010. PMID: 19523048

7

Comparison of biochemical safety between PEG-IFN alpha-2a and PEG-IFN alpha-2b.

Katano Y, Kumada T, Nakano I, Toyoda H, Ishigami M, Hayashi K, Honda T, Goto H. Katano Y, et al. Among authors: toyoda h. Hepatogastroenterology. 2009 Mar-Apr;56(90):485-91. Hepatogastroenterology. 2009. PMID: 19579626

8

Prevalence and clinical characterization of patients with acute hepatitis B induced by lamivudine-resistant strains.

Hayashi K, Katano Y, Ishigami M, Itoh A, Hirooka Y, Nakano I, Yoshioka K, Yano M, Toyoda H, Kumada T, Goto H. Hayashi K, et al. Among authors: toyoda h. J Gastroenterol Hepatol. 2010 Apr;25(4):745-9. doi: 10.1111/j.1440-1746.2009.06118.x. Epub 2010 Jan 13. J Gastroenterol Hepatol. 2010. PMID: 20074155

9

Association of interleukin 28B and mutations in the core and NS5A region of hepatitis C virus with response to peg-interferon and ribavirin therapy.

Hayashi K, Katano Y, Honda T, Ishigami M, Itoh A, Hirooka Y, Ishikawa T, Nakano I, Yoshioka K, Toyoda H, Kumada T, Goto H. Hayashi K, et al. Among authors: toyoda h. Liver Int. 2011 Oct;31(9):1359-65. doi: 10.1111/j.1478-3231.2011.02571.x. Epub 2011 Jun 23. Liver Int. 2011. PMID: 21745312

10

Prevalence of hepatitis C virus genotype 1a in Japan and correlation of mutations in the NS5A region and single-nucleotide polymorphism of interleukin-28B with the response to combination therapy with pegylated-interferon-alpha 2b and ribavirin.

Hayashi K, Katano Y, Kuzuya T, Tachi Y, Honda T, Ishigami M, Itoh A, Hirooka Y, Ishikawa T, Nakano I, Urano F, Yoshioka K, Toyoda H, Kumada T, Goto H. Hayashi K, et al. Among authors: toyoda h. J Med Virol. 2012 Mar;84(3):438-44. doi: 10.1002/jmv.23207. J Med Virol. 2012. PMID: 22246829

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,448 results

Search Page